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Abstract
Background: There is currently no effective preoperative assessment for patients undergoing kidney transplantation that is
able to identify those at high perioperative risk requiring admission to critical care unit (CCU). We sought to determine if
functional measures of cardiovascular reserve, in particular the anaerobic threshold (VO2AT) could identify these patients.
Methods: Adult patients were assessed within 4 weeks prior to kidney transplantation in a University hospital with a 37-bed
CCU, between April 2010 and June 2012. Cardiopulmonary exercise testing (CPET), echocardiography and arterial
applanation tonometry were performed.
Results: There were 70 participants (age 41.7614.5 years, 60% male, 91.4% living donor kidney recipients, 23.4% were
desensitized). 14 patients (20%) required escalation of care from the ward to CCU following transplantation. Reduced
anaerobic threshold (VO2AT) was the most significant predictor, independently (OR = 0.43; 95% CI 0.27–0.68; p,0.001) and
in the multivariate logistic regression analysis (adjusted OR = 0.26; 95% CI 0.12–0.59; p = 0.001). The area under the receiver-
operating-characteristic curve was 0.93, based on a risk prediction model that incorporated VO2AT, body mass index and
desensitization status. Neither echocardiographic nor measures of aortic compliance were significantly associated with CCU
admission.
Conclusions: To our knowledge, this is the first prospective observational study to demonstrate the usefulness of CPET as a
preoperative risk stratification tool for patients undergoing kidney transplantation. The study suggests that VO2AT has the
potential to predict perioperative morbidity in kidney transplant recipients.
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Introduction
A successful kidney transplant reduces the cardiovascular
mortality risk when compared with maintenance dialysis therapy
and relies on survival beyond the perioperative period [1,2].
Currently, there is no definitive consensus on the optimal pre-
kidney transplant cardiac assessment strategy to produce a
reliable prediction of perioperative morbidity following kidney
transplantation. Intraoperative oxidative stress during surgery
induces an increase in myocardial oxygen demand that is
further exacerbated by perioperative fluid shift [3]. Patients with
kidney failure have pre-existing co-morbid illness that contrib-
utes to structural cardiac and vascular alterations (myocardial
fibrosis, excessive arterial calcification, intimal hyperplasia) [4,5].
These complex cardiovascular alterations affect microvascular
flow and myocardial turgor, thereby are not conducive in
augmenting stroke volume or sustaining large volume cardiac
output [6].
The main novelty of cardiopulmonary exercise testing (CPET)
lies in its ability objectively to measure cardiovascular functional
reserve, in contrast to other tools frequently used to assess
cardiac function such as echocardiography or cardiac magnetic
resonance (CMR) which focus mainly on left ventricular (LV)
morphology [7–9]. CPET induces cardiovascular stress through
incremental level of work and determines the ability of the
cardiovascular system to drive and sustain the coupling between
the cellular and pulmonary respirations under stress conditions
[10–12]. The potential diagnostic utility of CPET for exercise-
induced myocardial ischemia causing LV dysfunction has also
been demonstrated in previous studies [13,14]. Therefore, the
large amount of data generated by CPET could be used
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objectively to evaluate cardiovascular response to physiologically
induced stress.
Several studies have demonstrated that non-invasive CPET
derived measures of cardiovascular reserve, especially the anaer-
obic threshold (VO2AT) provide a reliable predictor of perioper-
ative complications and mortality following major intra-abdominal
surgery [15–18]. However, there is currently no such effective
preoperative risk stratifying assessment for kidney transplant
recipients. The goal of this prospective study is to examine the
usefulness of CPET as a risk stratification tool for patients
undergoing kidney transplantation. We hypothesized that func-
tional quantification of cardiovascular reserve will identify kidney
transplant recipients who have a high risk of developing




The study protocol was approved by the Black Country
Research Ethics Committee (REC reference number: 09/
H1202/113).
Study Design
All patients aged 18 or over undergoing kidney transplanta-
tion at the University Hospitals Coventry and Warwickshire
NHS Trust (United Kingdom) were invited to participate within
4 weeks prior to the surgery between April 2010 and June
2012. These patients had previously undergone standard kidney
transplant work-up according to our center’s protocol that
included clinical evaluation, chest X-ray, electrocardiogram and
echocardiography. Each prospective transplant recipient was
evaluated by a transplant physician and a transplant surgeon.
Thallium myocardial perfusion imaging, exercise tolerance test,
coronary angiography, pulmonary function test and imaging of
the iliac vessels were performed selectively as determined by the
clinical assessment during the work-up period. All transplant
recipients were reviewed by the anesthetist 6–36 hours prior to
surgery.
For the purpose of this study, all recruited patients underwent
the additional CPET, arterial applanation tonometry and a study-
specified echocardiography within 4 weeks prior to transplanta-
tion. CPET data were not used to determine the inclusion or
exclusion of prospective kidney transplant recipients. All assess-
ments at study entry were carried out on the first non-dialysis day
for living donor kidney transplant recipients who were hemodi-
alysis dependent and prior to first antibody removal therapy with
double filtration plasmapheresis (desensitization) for those who had
donor kidney directed antibodies [19]. Recipients of kidneys from
deceased donors were approached on the day of admission and
assessed prior to surgery. All participants were recruited as part of
an ongoing prospective, longitudinal, non-randomized concurrent
control study, designed to determine the impact of kidney
transplantation on functional cardiovascular reserve and LV
dimensions, whereby patients were re-evaluated with CPET and
echocardiography at 60 days and 1 year following transplantation.
Patients with conditions precluding exercise testing were excluded.
Written informed consent was obtained from all eligible partic-
ipants.
The main outcome of interest was unplanned admission to
CCU due to post-operative requirement for invasive or intensive
central hemodynamic monitoring allowing for accurate infusion
of volume expanders or circulatory support with vasoactive
drugs. Indications for this were persisting hemodynamic
instability alone or hemodynamic instability in patient with
sepsis. Hemodynamic instability was defined as persistently low
systolic arterial blood pressure (#85 mmHg) despite adequate
blood volume expansion targeted to a central venous pressure of
10–12 mmHg and as determined by clinicians in the ward. In
addition, an observation based modified early warning scoring
system (MEWS) [20,21] was used to trigger early assessment
and intervention on the ward. Involved clinicians were blinded
to the CPET results.
Clinical Data
Baseline clinical and demographic data were recorded
including weight, height, body mass index (BMI), duration of
CKD and dialysis vintage. Assessment of traditional cardiovas-
cular risk factors included a history of any of the following: (1)
A previous coronary artery disease event (CAD: nonfatal
myocardial infarction, acute coronary syndrome requiring
hospitalization, percutaneous coronary intervention or coronary
artery bypass graft), (2) cerebrovascular disease (CVD: transient
ischemic attack or stroke), (3) diabetes (use of oral hypoglyce-
mics or insulin), (4) dyslipidemia (use of lipid-lowering therapy),
(5) hypertension (use of antihypertensives), and (6) smoking
status (ever or never). Serial 12-lead electrocardiograms were
performed at study entry, during hospital admission for surgery
(including the pre-, peri- and postoperative period as well as
during stay in the CCU) and at clinic visit, 60 days following
transplantation. All kidney transplant recipients who were
admitted to CCU were identified. Length of stay in the CCU
and hospital were recorded.
Cardiopulmonary Exercise Testing
Prior to exercise testing, forced expiratory volume in 1 sec
(FEV1) and full vital capacity (FVC) of the lungs were measured.
Exercise testing to maximal exhaustion using cycle ergometer
ramping protocol, incorporating an individualized work rate was
performed. Minute ventilation (VE), oxygen consumption (VO2),
carbon dioxide production (VCO2) and other associated param-
eters were acquired via breath-by-breath analysis (VIASYS,
MasterScreen CPXH, Hoechberg, Germany). The metabolic cart
was recalibrated for consecutive patients. A 12-lead electrocardio-
gram was recorded continuously throughout testing and during
recovery. Test was terminated at maximal exhaustion, accompa-
nied by attainment of a respiratory exchange ratio (RER, ratio of
CO2 production to O2 consumption) of a value $1.15. VO2peak
was measured as the highest VO2 achieved during the final 30 sec
of peak exercise. VO2AT was determined by the V-slope method
in conjunction with analyses of the ventilatory equivalents (VE/
VO2 and VE/VCO2) and end-tidal gas tensions (PETO2 and
PETCO2) plots [22]. This was undertaken by two experienced
investigators.
Echocardiographic Study
2-dimensional echocardiography and Doppler blood flow
measurements were performed [23]. Calculations included left
LV diastolic and systolic volumes, LV mass, ejection fraction
(LVEF) according to Simpson’s method and left atrial volume
(LAV). Mitral inflow measurements included peak early (E) and
late (A) flow velocities. Tissue Doppler imaging of the mitral
annulus, sequentially at the lateral and septal annular sites were
obtained from the apical 4-chamber view. The ratio of early
transmitral flow velocity to averaged annular (septal and lateral)
mitral velocity (E/E’) was taken as an estimate of LV filling
pressure.
Functional Cardiovascular Reserve in CKD Patients
PLOS ONE | www.plosone.org 2 May 2013 | Volume 8 | Issue 5 | e64335
Arterial Applanation Tonometry
The SphygmoCor System (AtCor Medical Pty Ltd., Australia)
was used to evaluate arterial compliance. Aortic pulse wave-form,
augmentation pressure, and augmentation index were derived by
tonometric applanation of the radial artery. Using similar
technique, carotid-femoral pulse wave velocity (PWV) was
determined from the time taken for the arterial pulse to propagate
from the carotid to the femoral artery. A minimum of 3 readings
were obtained for all parameters.
Statistical Methods
Results are expressed as mean, median or frequencies with
corresponding confidence interval (CI) estimates depending on the
distribution and type of the variable. Logistic regression was
utilized to calculate odds ratios (ORs) with 95% CI limits for risk
factors of CCU admission. Multiple (binary) logistic regression
models were fitted to identify a prediction model for CCU
admission. For this, risk factors which were significant in the
univariate modeling (plus known confounders) were considered for
the model allowing multiple predictor variables. Three different
effect selection methods (forward selection, backwards elimination
and stepwise selection) were used for the multiple logistic
Table 1. Baseline characteristics of the patients.
Characteristics Non-CCU patients (N = 56) CCU patients (N = 14) Difference (95% CI)
Age, years 39.8614.2 49.9612.4 10.1 (2.1–18.7)
Male, n (%) 38 (67.8) 4 (28.6) 239.2 (259.3– 210.1)(1)
Caucasian, n (%) 47 (83.9) 13 (92.8) 8.9 (222.0–16.5)(1)
BMI, kg/m2 24.863.7 24.663.3 20.2 (22.4–1.9)
Desensitized, n (%) 7 (12.5) 8 (57.1) 44.6 (17.7–67.0)(1)
CKD duration, months 114.0 (46.5–210.3) 200.5 (93.0–270.0) 60.0 (0.0–132.0)(2)
Dialysis duration, months 4.5 (0.0–26.8) 32.0 (18.8–89.5) 24.0 (6.0–36.0)(2)
Pre-dialysis, n (%) 24 (42.9) 1 (7.2) 235.7 (28.6– 250.0)(1)
Dialysis-dependent, n (%) 32 (57.1) 13 (92.8) 35.7 (8.6–50.0)(1)
Resting blood pressure
Systolic, mmHg 137.3620.6 137.6616.8 0.3 (211.5–12.3)
Diastolic, mmHg 82.2612.3 80.466.4 21.8 (28.7–4.9)
Cardiovascular risk factors
Hypertension (%) 52 (92.9) 12 (85.7) 27.1 (233.2–7.1)(1)
Dyslipidemia (%) 20 (35.7) 6 (42.8) 7.1 (218.0–34.2)(1)
Diabetes (%) 5 (8.9) 2 (14.3) 5.4 (29.2–31.5)(1)
Tobacco (%) 28 (50.0) 6 (42.8) 27.1 (232.1–20.5)(1)
CAD (%) 3 (5.4) 0 (0.0) 25.4 (214.6–16.4)(1)
CVD (%) 3 (5.4) 0 (0.0) 25.4 (214.6–16.4)(1)
Blood parameters
Hemoglobin, g/dl 11.861.4 11.4462.1 20.4 (21.4–0.4)
C-reactive protein, mg/L 0.0 (0.0–6.0) 4.5 (0.0–9.7) 0.0 (0.0–5.0)(2)
Albumin, g/L 44.0 (42.0–46.0) 43.5 (39.0–45.0) 21.0 (23.0–1.0)(2)
Spirometry
FEV1, % predicted 89.1618.6 83.9621.5 25.2 (219.7–3.6)
FEV1/FVC 75 (72–83) 76 (68.8–77.3) 22.0 (27.0–2.0)
(2)
Arterial compliance
PWV, m/s 7.4 (6.4–8.8) 8.2 (7.4–10.3) 0.9 (20.2–2.0)(2)
Augmentation index, % 20.6615.3 26.5612.8 5.9 (23.7–14.0)
CPET variables
VO2AT, ml/min/kg 12.562.2 9.761.7 22.8 (24.1– 21.6)
VO2peak, ml/min/kg 22.165.8 16.864.3 25.3 (28.6– 22.0)
Oxygen pulse (ml O2/min) 11.864.5 9.062.4 22.8 (25.3– 20.3)
VE/VCO2 slope 31.266.6 33.965.2 2.7 (21.2–6.4)
Data are mean 6 SD, median (IQR) or frequencies (%). BMI, body mass index; CI, Confidence interval; CKD, chronic kidney disease; CAD, coronary artery disease; CVD,
cerebrovascular disease; FEV1, forced expiratory volume in 1 sec; FVC, full vital capacity; PWV, carotid-femoral pulse wave velocity; CPET, cardiopulmonary exercise
testing; VO2AT, anaerobic threshold; VO2peak, oxygen consumption at maximal exercise. VE/VCO2 (ventilatory efficiency) measured from the start of unloaded pedaling
to maximal exercise. (1) Differences for non-continuous variables are expressed as relative frequency differences with corresponding Wilson Score confidence limits. (2)
Differences for non-normal continuous variables are expressed as Hodges-Lehmann location shifts and Hodges-Lehmann confidence limits.
doi:10.1371/journal.pone.0064335.t001
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regression modeling to evaluate the consistency of results. A p-
value ,0.05 was required for effect inclusion in the multivariate
modeling and an effect elimination criterion of p,0.10 was
chosen. To evaluate the accuracy of different VO2AT ‘cut-off’
values to predict CCU admission, ordinary and cross validated
receiver operating characteristic (ROC) curves and area under
curve (AUC) estimates were calculated. The optimal cut-off is
estimated based on the Youden index criterion [24] which is
optimal in the sense that it provides a score which reflects the
intention of maximizing the overall correct classification rate. All




Eighty-one patients were screened for inclusion into the study
and seventy individuals were included after the exclusions of
eleven (one patient aged ,18 years, one had myopathy secondary
to mitochondrial cytopathy, one deceased kidney transplant
recipient due to inadequate time for complete assessment and
eight patients did not provide consent). Analysis of unplanned
CCU admitted patients included the fourteen patients who fulfilled
the study-defined indications for CCU admission. One patient
who was admitted to CCU electively from theatre for a non-study
indication (telemetry monitoring due to prior history of ischemic
cardiomyopathy) was grouped as ‘non-CCU’.
Baseline characteristics of seventy CKD patients are shown in
Table 1. 91.4% of patients received kidneys from living donors and
8.6% were deceased kidney transplant recipients. Mean age of all
patients was 41.7614.5 years and 60% were male. Fifteen
recipients (23.4%) of antibody-incompatible living-donor kidneys
were treated with plasmapheresis based antibody removal
protocol. Following transplantation, fourteen patients (20%)
required escalation of care from the ward to CCU. Patients
admitted to CCU were predominantly female (71.4%) compared
to non CCU patients (32.2%) (Difference D= 39.2%, 95% CI
16.9–67.9). CCU patients were older (49.9612.4 years) compared
to patients that did not require critical care support (39.8614.2
years) (D= 10.1, 95% CI 2.1–18.7). Forty-five (64.3%) patients
were dialysis dependent prior to transplantation and 28.9% of
these patients required critical care support following surgery.
More than half of those who had antibody removal therapy
(57.1%) required CCU support following transplantation
(D= 44.6%, 95% CI 16.9–67.9). There were no associations
between preexisting coronary artery disease and diabetes with
CCU admissions.
Admission to CCU within 24 hours following transplantation
was documented in twelve patients whilst two patients had
escalation of care to CCU more than a week following
transplantation (day 10 and day 12 respectively). Hemodynamic
instability (systolic arterial blood pressure #85 mmHg) accounted
for all CCU admissions including two patients who also had sepsis
(Gram negative bacteremia). 71.4% of CCU admitted patients
received intravenous vasopressors whilst four patients had intra-
arterial blood pressure and central venous pressure measurements
to guide volume expansion without the eventual need for
vasoactive drugs. There were no ischemic or arrhythmic ECG
changes during the peri- and post-operative period; and at 60 days
follow-up in all patients. The average duration of stay for those
admitted to CCU was 3 days and this group had a longer hospital
stay following transplantation (9 days, IQR: 7–15) versus those
that were not admitted to CCU (7 days, IQR: 6–8; p = 0.02). No
major cardiovascular events (death, myocardial infarction or non-
fatal angina) were recorded at 60 days post transplantation.
LV Morphology among Kidney Transplant Recipients
Kidney transplant recipients had a mean LVEF of 59.969%
and the echocardiographic indices were not statistically different
between patients who were in CCU and those that did not require
admission to CCU (Table 2). Univariate logistic regression
modeling did not yield a significant association between preoper-
ative LVEF, LV mass, LV filling pressure (diastolic compliance) or
LA volume with the risk of CCU admission (Figure 1).
Functional Measures of Cardiovascular Reserve
All seventy patients completed maximal exercise testing,
accompanied by a mean RER of 1.2560.12. The mean RER at
the point of VO2AT was 0.8860.07. The mean duration of
freewheel and loaded pedaling was 10.5062.02 minutes. Univar-
iate logistic regressions for CPET variables’ association with CCU
admission are summarized in Figure 2. Low levels of VO2AT,
VO2max, oxygen pulse and maximum work rate were significantly
associated with admission to CCU following transplantation.
Measure of VO2AT was strongly correlated with VO2peak
(r = 0.77, 95% CI 0.65–0.85), oxygen pulse (r = 0.54, 95% CI
0.35–0.69) and maximum work rate (r = 0.55, 95% CI 0.36–0.69)
(Table 3). The mean VO2AT was significantly lower in the CCU
admitted compared to non CCU patients (p,0.001) (Table 1 and
Figure 3).
Predictors of CCU Admission
To derive a prognostic model for CCU admission, multiple
logistic regression models were fitted. Predictors which were
significant in the univariate analysis were admitted to the
multivariate modeling. Dialysis vintage and BMI are known
confounders of cardiovascular and postoperative morbidity [25–
27], and were therefore included in the initial set of risk predictors.
Known cardiovascular risk factors were included in the variable
selection process so that a total of 11 variables were considered.
The established risk factors CVD and CAD (CVD/CAD) were
omitted as odds ratio estimates are unobtainable due to the
absence of prior history of CVD/CAD in CCU admitted patients.
Table 4 shows the predictor’s ORs and 95% CIs estimated from
univariate and multivariate models. Our primary research
hypothesis concerned the association of VO2AT and CCU
admission. Therefore, and because of its high reproducibility
[28] and strong correlation (multicolinearity) with the VO2max,
Figure 1. Univariate logistic regression of major echocardio-
graphic parameters and CCU admission. LVEF, LV ejection
fraction; LVMI, LV mass index corrected to body surface area; E/E’, ratio
of early transmitral flow velocity to annular mitral velocity (averaged of
septal and lateral); LAVI, left atrial volume index corrected to body
surface area. OR, odds ratio; Horizontal bars represent the 95% CI. One
metric unit increase in the parameters is associated with the odds of
CCU admission.
doi:10.1371/journal.pone.0064335.g001
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oxygen pulse and maximal work rate (Table 3), VO2AT was
selected for the multivariate modeling and other significant CPET
variables were not. Though insignificant in the univariate analysis,
patients with a higher BMI had reduced odds of CCU admission
in the multivariate analysis (adjusted OR = 0.72, 95% CI 0.52–
0.99, p = 0.04). Figure 4 shows preoperative variables included in a
multivariate model by variable selection procedures. The final risk
prediction model consists of 3 predictors: VO2AT, BMI and
desensitization status; model-building strategies forward selection,
backwards elimination and stepwise variable selection resulted in
the same model. The Hosmer-Lemeshow test is not significant,
indicating that there is no evidence for lack of fit in the final
multiple logistic regression model (chi-square = 6.71, degree of
freedom = 8, p = 0.57). The area under the ROC curve is 0.93,
indicating a very high probability of correctly classifying a
randomly chosen pair consisting of a patient who requires CCU
admission and a patient who does not (Figure 5). Using cross-
validation to obtain an unbiased estimate results in an AUC of
0.90. An equation based on the model that allows estimation of the
probability of CCU admission following kidney transplantation is
described as follows:-.
Calculation of the predicted risk using patient’s data and
multivariate logistic regression model. The odds of admis-
sion to CCU following kidney transplantation is calculated as
odds = exp[27.003+
(21.3346VO2AT)+(20.3346BMI)+(22.3426 Desensitization
status)]. The measured values are entered for the risk variables
VO2AT and BMI, whilst desensitization status is coded as either 1
Table 2. Echocardiographic indices for all patients.
Indices All patients (N = 70) Non-CCU patients (N = 56) CCU patients (N = 14) p –value
LVEF, % 59.969 58.868.9 63.468.2 0.08
Fractional shortening, % 31.766.6 31.766.7 31.866.3 0.92
LA diameter, cm 3.560.7 3.560.7 3.560.6 0.89
LAVI, mL/m2 25.4610.2 24.467.7 29.8617.2 0.07
LVMI, g/m2 118.8642.6 119.2639.5 117656.4 0.87
LVH, n (%) 30 (42.9) 25 (44.6) 5 (35.7) 0.55
LV mass categorization 0.80
Normal, n (%) 13 (18.6) 11 (20) 2 (13.3)
Concentric remodelling, n (%) 27 (38.6) 20 (36.4) 7 (46.7)
Concentric LVH, n (%) 23 (32.9) 19 (33.9) 4 (28.6)
Eccentric LVH, n (%) 7 (10) 6 (10.9) 1 (6.7)
E/A 1.160.4 1.160.4 160.4 0.48
Deceleration time, ms 216.6649 215.3651 221.5643 0.62
IVRT, ms 91626.8 91.1624.5 90.5636.7 0.94
E/E’ 8.363.2 8.263.4 8.862.7 0.57
Data are mean 6 SD or frequencies (%). Analysed using independent samples t-test or x2.LVEF, LV ejection fraction; LA, left atrium; LAVI, left atrial volume index
corrected to body surface area; LVMI, LV mass index corrected to body surface area; LVH, left ventricular hypertrophy; E/A, the ratio of peak early to late transmitral
ventricular filling velocities; IVRT, isovolumic relaxation time; E/E’, ratio of early transmitral flow velocity to annular mitral velocity (averaged of septal and lateral).
doi:10.1371/journal.pone.0064335.t002
Figure 2. Univariate logistic regression of CPET derived measures of cardiovascular reserve and CCU admission. VO2peak, oxygen
consumption at maximal exercise; VO2AT, anaerobic threshold; VE/VCO2 (ventilatory efficiency) measured from the start of unloaded pedaling to
maximal exercise. OR, odds ratio; Horizontal bars represent the 95% CI. One metric unit increase in the parameters is associated with the odds of CCU
admission. *p,0.05.
doi:10.1371/journal.pone.0064335.g002
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(yes) or 0 (no). The predicted risk (probability) of CCU admission
following kidney transplantation is calculated as odds/1+ odds.
Considering the variable VO2AT univariately as a predictor
yields an optimal cut-off of VO2AT = 11.31 ml/min/kg for
distinguishing between the CCU admitted and non-admitted
populations (Youden index J = 0.68). This translates into a
sensitivity of 92.9% and a specificity of 75.0% at this cut-off point.
Discussion
This is the first prospective study to demonstrate an indepen-
dent association between objective indices of cardiovascular
reserve, in particular the VO2AT, measured preoperatively and
CCU admission following kidney transplantation. In the preop-
erative assessment setting of major intra-abdominal surgery (all
previous studies precluded kidney transplantation), three physio-
logical CPET variables have been shown effectively to identify
high risk patients: VO2AT [15,16], VO2peak [18] and ventilatory
equivalent for carbon dioxide (VE/VCO2) [16,17]. This study
identifies similar importance of VO2peak and VO2AT, with the
additional measures of oxygen pulse and maximal work rate as
markers of high perioperative risks (Figure 2). The index of VE/
VCO2 appears not to have any significant preoperative risk
predicting strength among CKD patients. VO2AT is defined as
the point during incremental exercise when oxygen demand
exceeds oxygen delivery, thus causing the anaerobic metabolism to
make up the deficit, with a consequential rise in serum lactate
concentration. It is a measure of the ability of the cardiovascular
system to deliver adequate oxygen to tissue and possesses the
advantage over VO2peak, of being independent of patient
motivation or premature termination of test [28]. Among the
CPET variables in this study, measure of sustainable oxygen
consumption (VO2AT) carries the strongest risk predicting
strength independently (Figure 2) and remains significant after
adjusting for age and gender (Table 4), attesting to the study’s
hypothesis that reduced objective measure of cardiovascular
reserve is associated with an increased perioperative morbidity.
In contrast with other studies [15–18], low VO2AT among
kidney transplant recipients does not carry any risk of death or
cardiac ischemia at 60 days following surgery. This is despite the
fact that a similar proportion of patients (33%) who underwent
surgery had an VO2AT of less than 11 ml/min/kg in this study
compared with previous studies, such as 29% in the one by Older
and colleagues [15]. This suggests that the prognostic values of
VO2AT in other major intra-abdominal studies may not be
transferable to kidney transplantation. The study also shows no
associations between the static measures of cardiac function
(echocardiography) or aortic compliance and perioperative risk
among CKD patients. Additionally, there were no events of
cardiac ischemia during the perioperative period to 60 days
following surgery. The relevance of these is in keeping with the
findings of a recent preoperative (kidney transplant) cardiac
assessment study that demonstrated not only the low incidence of
cardiac ischemia perioperatively among high cardiac risk cohort
but also the lack of prognostic abilities of tools such as myocardial
scintigraphy, dobutamine stress echocardiography or coronary
angiogram (with subsequent revascularization if positive stress test)
in reducing perioperative cardiac events [29].
In antibody incompatible transplantations, patients receive
more cumulative immunosuppression treatment, including plas-
mapharesis and anti-thymocyte globulin [19,30], which increase
the risk of sepsis. However, among the eight desensitized patients
admitted to CCU, only one required admission following a
development of neutropenic sepsis and hypotension, 10 days
following kidney transplantation. Adverse cardiovascular effects of
the standard oral immunosuppressive therapies usually occur over
time and are unlikely to have any direct impact on perioperative
outcome [31]. However, the insult of sepsis can expose the limits of
patient’s cardiovascular reserve. The hemodynamic profile of
sepsis includes loss of vascular responsiveness and decrease venous
return to the heart resulting in a decrease in cardiac output
Figure 3. Anaerobic threshold measurements in CCU admitted
and non CCU patients. Horizontal lines refers to mean values of
anaerobic threshold (VO2AT). Squares are VO2AT of non CCU patients
and triangles are VO2AT of CCU admitted patients. *The p-value of the
difference in the mean values of VO2AT between CCU admitted and
non CCU patients.
doi:10.1371/journal.pone.0064335.g003
Table 3. Correlation between VO2AT and other CPET-derived
indices of cardiovascular reserve (n = 70).
Parameters R 95% CI p – value
VO2peak (ml/min/kg) 0.77 0.65–0.85 ,0.001*
Oxygen pulse (ml of O2/beat)
a 0.54 0.35–0.69 0.02*
Maximal work (Watt) 0.55 0.36–0.69 0.01*
aLogarithmic transformation applied for analysis; r, Pearson’s correlation
coefficient; Fisher’s z-transformation has been used to derive CIs and p-values
under the null hypothesis H0: r = 0.3.
*p,0.05.
doi:10.1371/journal.pone.0064335.t003
Figure 4. Final risk-prediction model based on 3 predictors of
CCU admission. One metric unit increase in the parameters (except
desensitization status) is associated with the odds of CCU admission.
*Desensitization (none) = No desensitization therapy is associated with
decrease odds in CCU admission. OR, odds ratio; Horizontal bars
represent the 95% CI.
doi:10.1371/journal.pone.0064335.g004
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[32,33]. Therefore, rapid fluid therapy at the early stage of sepsis is
vital. It also modulates inflammation and prevents further
myocardial depression caused by inflammatory cytokines [34].
Hypotension after adequate restoration of LV preload with
volume expansion could largely be related to impairment of
cardiovascular contractility [35,36]. It could also be speculated
that, the subclinical effects of myocardial stunning on the LV,
induced by hemodialysis [37,38] could be exaggerated by
additional high volume plasmapheresis therapy [19,30] causing
further reduction to the functional cardiovascular reserve, that
were measured prior to the start of desensitization treatment.
Hence, these crucial pre-operative treatment strategies could have
altered and increased patients’ surgical cardiac risk status at the
time of surgery. Furthermore, these patients also carried the
burden of disease chronicity greater than those who did not
require desensitization [dialysis vintage: 26 (15–106) vs. 6 (0–32)
months, p = 0.01; CKD duration: 192 (84–252) vs. 120 (42–211)
months, p = 0.08). The effect of having no dialysis prior to kidney
transplantation on perioperative outcome was examined by
ordering patients into 2 groups: pre-dialysis and dialysis depen-
dent. Even though dialysis vintage did not appear to contribute to
the risk of perioperative need for CCU, patients who were
transplanted pre-emptively had a lower risk of CCU admission
than those who were dialysis dependent (Table 1).
PWV was found to be insignificant in predicting perioperative
morbidity in this study (Table 4). This could be due to the fact that
PWV provides information on the stiffness of the local vessels
being studied rather than the systemic arterial stiffness [39]. The
latter along with cardiac output ( = stroke volume 6 heart rate)
are determinants of the mean arterial pressure which is an
indicator of hemodynamic stability. Although this finding also
reflects the limitation of using single surrogate marker as a risk
predictor, the value of PWV should not be underestimated due to
the recognized pathophysiological role of central arterial stiffness
on LV afterload [40]. The outgoing systolic pressure wave that
traverses the stiffened aorta is reflected early causing an increase in
the augmentation and central pulse pressures. The premature
reflection of the systolic waveform also shortens the critical
diastolic phase during which the coronaries are being perfused
with the end result of myocardial depression [40,41]. This may
explain the inverse correlation between PWV and AT as a global
measure of functional cardiovascular reserve in our cohort
(Pearson correlation, r = 20.32, p = 0.007).
Many nephrologists and transplant surgeons have concerns
about the higher rates of postoperative complications in
overweight patients with their possible effects on survival outcomes
and hence patients with BMI greater than 35 kg/m2 are
suspended from transplantation. However, it is important to note
that this study has shown that lower BMI is associated with
Figure 5. Accuracy in Predicting CCU Admission of the Final
Model using Receiver Operator Characteristics (ROC) Curves.
doi:10.1371/journal.pone.0064335.g005
Table 4. Associations between preoperative anaerobic threshold, clinical variables, arterial compliance and CCU admission
(n = 70).
Parameters Univariate{ OR (95% CI) p-value First Model` OR (95% CI) p-value Final Model` OR (95% CI) p-value
VO2AT, ml/min/kg 0.43 (0.27–0.68) ,0.001* 0.33 (0.14–0.78) 0.01* 0.26 (0.12–0.59) 0.001*
BMI, kg/m2 0.98 (0.83–1.16 ) 0.82 0.70 (0.45–1.08) 0.11 0.72 (0.52–0.99) 0.04*
Desensitization (none) 0.11 (0.03–0.40) 0.001* 0.05 (0.01–0.49) 0.01* 0.10 (0.02–0.58) 0.01*
Age, year 1.05 (1.01–1.10) 0.02* 1.07 (0.97–1.17) 0.17 – –
Gender (male) 0.19 (0.05–0.69) 0.67 0.47 (0.04–5.32) 0.54 – –
Dialysis vintage, months 1.00 (0.99–1.01) 0.44 0.99 (0.98–1.01) 0.65 – –
Hypertension 0.46 (0.08–2.82) 0.40 0.30 (0.02–4.67) 0.39 – –
Dyslipidemia 1.35 (0.41–4.44) 0.62 1.11 (0.14–8.66) 0.92 – –
Diabetes 1.77 (0.29–1.84) 0.55 0.29 (0.02–5.16) 0.39 – –
PWV, m/s 1.08 (0.89–1.31) 0.45 – – – –
Augmentation index, % 1.03 (0.98–1.07) 0.25 – – – –
{Univariate logistic regression.
`Multiple (binary) logistic regression modeling.
*p,0.05.
doi:10.1371/journal.pone.0064335.t004
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significant perioperative morbidity after adjusting for important
covariates as shown in Table 4. This confirms the findings of other
observational studies that low BMIs, often associated with low
VO2peak in hemodialysis patients [42], also carries a high
morbidity risk among kidney transplant recipients [43]. Here, it
may also be important to recognize the relevance of the reverse
epidemiology observed in end-stage renal disease patients in whom
high BMI is paradoxically protective [44,45].
The prognostic value of VO2AT is demonstrated in the risk-
prediction model that included both the BMI and desensitization
status (Figure 5). The AUC was 0.93 for the ROC curve using all
the available data to estimate these parameters (Model 0) and
using cross validation (Model 1), the AUC was still very high albeit
reduced to 0.90. These findings demonstrate that in combination,
these 3 variables perform well as a preoperative risk stratification
tool for predicting perioperative morbidity among kidney trans-
plant recipients leading to CCU admission.
Even though the design of this study was prospective, the
limitation was the relatively small sample size. The study was also
not powered for mortality. However, there were no deaths despite
the lowest measured VO2AT being 6.7 ml/min/kg. The majority
of CKD patients in this study were kidney recipients of living
donor and the results presented here may not be reflective in a
study cohort that consisted only of deceased kidney recipients.
However, the risk may be comparable to patient population
undergoing antibody removal. On the intention-to-treat basis, this
study was designed to include all patients including those with high
immunological risk. Therefore, the relatively higher than expected
rate of CCU admission in our cohort may be due to the large
numbers of antibody-incompatible kidney transplants performed
in our center compared to an average kidney transplant unit.
Finally, questions remain, whether the CPET derived markers of
cardiovascular reserve could be modified or improved (example,
with individualized exercise training) with a subsequent reduction
in the perioperative risk associated with kidney transplantation or
if the measure of VO2AT could improve the transplant work-up
process and increase the inclusion of patients into the transplant
programme, who are otherwise excluded based on current clinical
criterions.
Conclusions
This is the first prospective study to demonstrate the usefulness
of CPET as a preoperative risk stratification tool for patients
undergoing kidney transplantation. The study suggests that
objective measures of functional cardiovascular reserve, in
particular the VO2AT, have the potential to predict perioperative
morbidity in kidney transplant recipients. A further study of larger
sample is required to validate the findings.
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